Form 4: LeonaBio Director Acquires Stock Options

LeonaBio, Inc. director Peter B. Silverman acquired stock options as part of the company's Outside Director Compensation Policy.

Summary

• Peter B. Silverman, a Director at LeonaBio, Inc., was granted stock options on June 23, 2026.
• The options have an exercise price of $8.35 and are for 2,333 shares of common stock.
• These options are part of the company's Outside Director Compensation Policy.
• The shares subject to the option will vest on the earlier of June 23, 2027, or the day before the next annual stockholder meeting after June 22, 2026.
• The grant is pro-rated based on Silverman's appointment to the board on May 5, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard director compensation event rather than a significant financial or strategic development.

Positives

• Director compensation aligns with company stock performance through options.
• Granting options to directors can incentivize long-term value creation.
• The pro-rated grant reflects Silverman's partial tenure on the board.

Risks

• The value of the stock options is subject to the future performance of LeonaBio's stock price.
• Vesting schedules may not align with immediate strategic goals if the stock price fluctuates significantly before vesting.

Future Outlook

The future outlook for the stock options is dependent on the company's stock performance and the vesting schedule outlined.

Management Comments

• The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026.
• The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy and is pro-rated based on the reporting person's appointment to the Issuer's board of directors on May 5, 2026.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and life sciences sector, aligning executive and board incentives with shareholder value.

Corporate Governance

Related Party Transactions

• Grant of stock options to Director Peter B. Silverman.

Stakeholder Impact

• Shareholders: The grant of options aligns director incentives with potential stock appreciation, which can benefit shareholders if the company performs well.
• Directors: Provides potential financial upside tied to company performance.

Next Steps

• Vesting of stock options according to the defined schedule.
• Potential exercise of stock options if the stock price exceeds the exercise price.

Key Dates

Keywords

LeonaBio, LONA, Form 4, Stock Options, Director Compensation, Beneficial Ownership, SEC Filing, Securities Exchange Act